Novartis AG v FH Faulding & Co Ltd [2004] FCA 1002

Novartis AG v FH Faulding & Co Ltd [2004] FCA 1002

Although answers favourable to the respondents on the proposed preliminary questions would determine the proceeding, the respondents did not show that separate determination would clearly facilitate a quicker and cheaper resolution. If the questions were answered in favour of the applicant, there was a real risk of contested factual and expert issues being determined twice, overlapping evidence and cross-examination, appeals, duplicated interlocutory steps, added expense, delay and fragmentation. Those considerations outweighed the potential benefit of separate determination, so the discretion under Order 29 was not exercised in favour of the respondents.

Jurisdiction
Australia
Judgment Date
03 August 2004
Procedural Posture
Patent Infringement Proceeding / Interlocutory Motion by the Second Respondent for Separate Determination of Preliminary Questions Under Order 29 Rule 2(a) of the Federal Court Rules
Outcome
The motion for separate determination of preliminary questions was dismissed, with costs to the applicant.
Legal Topics
['patent Infringement' 'separate Determination of Questions' 'preliminary Questions' 'construction of Patent Claims' 'federal Court Rules O 29 R 2']
['intellectual Property' 'patents' 'civil Procedure'] ['patent Infringement' 'separate Determination of Questions' 'preliminary Questions' 'construction of Patent Claims' 'federal Court Rules O 29 R 2']

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 1 Authorities cited 2 Party arguments 2 Amounts and remedies 1
Sign in to unlock

Procedural Posture

Patent Infringement Proceeding / Interlocutory Motion by the Second Respondent for Separate Determination of Preliminary Questions Under Order 29 Rule 2(a) of the Federal Court Rules

Legal Issues

  1. 1 ["Whether the Court should order that proposed questions concerning whether Cysporin capsules or Cicloral capsules taken with water result in a 'pharmaceutical preparation' within claim 1 of Australian Letters Patent No 606,908 be determined separately and before trial." 'Whether determination of the proposed questions separately would substantially shorten the trial or save time and expense, or instead risk duplication, delay, overlap of expert evidence and fragmentation of the proceeding.' 'Whether the possibility that answers favourable to the respondents would dispose of the proceeding outweighed the consequences if the questions were answered in favour of the applicant.']

Ratio Decidendi

Although answers favourable to the respondents on the proposed preliminary questions would determine the proceeding, the respondents did not show that separate determination would clearly facilitate a quicker and cheaper resolution. If the questions were answered in favour of the applicant, there was a real risk of contested factual and expert issues being determined twice, overlapping evidence and cross-examination, appeals, duplicated interlocutory steps, added expense, delay and fragmentation. Those considerations outweighed the potential benefit of separate determination, so the discretion under Order 29 was not exercised in favour of the respondents.

Court Disposition

The motion for separate determination of preliminary questions was dismissed, with costs to the applicant.

Orders

  • ['The first paragraph of the motion notice of which was filed on 21 April 2004 be dismissed.' "The second respondent pay the applicant's costs of the first paragraph of the motion."]